Effect of adjuvant chemotherapy with docetaxel, cisplatin, and continuous infusion fluorouracil for gastric cancer: A phase II study

被引:0
|
作者
Zhao, L.
Ying, H.
Ning, X.
Zhou, J.
Wang, Y.
Bai, C.
Chen, S.
机构
[1] Chinese Acad Med Sci, Div Oncol, Dept Med, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[2] Beijing Union Med Coll Hosp, Beijing, Peoples R China
关键词
D O I
10.1200/jco.2010.28.15_suppl.e14652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14652
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Phase II study of docetaxel combined with cisplatin in advanced gastric cancer.
    Park, YS
    Park, KW
    Lee, J
    Kang, JH
    Kim, HY
    Park, JO
    Lee, SH
    Kang, WK
    Park, K
    Lee, SI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 327S - 327S
  • [22] Phase II study of induction chemotherapy and concomitant chemoradiotherapy with cisplatin and continuous infusion 5-fluorouracil (PF) for anal carcinoma
    Freire, J. G.
    Trindade, M. C.
    Barata, A. M.
    Venancio, J.
    Claro, I.
    Fernandes, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Hwang, Junyl
    Cho, Sang-Hee
    Shim, Hyun Jeong
    Lee, Se-Ryeon
    Ahn, Jae Sook
    Yang, Duk-Hwan
    Kim, Yeo-Kyeoung
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    Chung, Ik-Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 586 - 591
  • [24] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [25] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [26] A phase II study of Docetaxel and Oxaliplatin combination as first-line chemotherapy in recurrent gastric cancer patients after Fluoropyrimidine and/or Cisplatin adjuvant treatment
    Kang, H.
    Oh, S.
    Kim, J.
    Nam, S.
    Kim, B.
    Song, E.
    Cho, S.
    Baek, J.
    Jeung, H.
    Hong, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 375
  • [27] Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
    Hara, Hiroki
    Tahara, Makoto
    Daiko, Hiroyuki
    Kato, Ken
    Igaki, Hiroyasu
    Kadowaki, Shigenori
    Tanaka, Yoichi
    Hamamoto, Yasuo
    Matsushita, Hisayuki
    Nagase, Michitaka
    Hosoya, Yoshinori
    CANCER SCIENCE, 2013, 104 (11) : 1455 - 1460
  • [28] Phase. study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer
    Dassen, Anneriet E.
    Bernards, Nienke
    Lemmens, Valery E. P. P.
    van de Wouw, Yes A. J.
    Bosscha, Koop
    Creemers, Geert-Jan
    Pruijt, Hans J. F. M.
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 8 (10): : 706 - 712
  • [29] Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II Study
    Matsumoto, Akira
    Nishikawa, Katsunori
    Yuda, Masami
    Tanaka, Yujiro
    Tanishima, Yuichiro
    Arakawa, Yasuhiro
    Ishibashi, Yoshio
    Sakuyama, Toshikazu
    Omura, Nobuo
    Mitsumori, Norio
    Aiba, Keisuke
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2016, 36 (04) : 1937 - 1942
  • [30] Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer
    Shinkyo Yoon
    Changhoon Yoo
    Min-Hee Ryu
    Myoung Joo Kang
    Baek-Yeol Ryoo
    Sook Ryun Park
    Jeong Hwan Yook
    Sung Tae Oh
    Moon-Won Yoo
    Byung Sik Kim
    Yoon-Koo Kang
    Gastric Cancer, 2017, 20 : 182 - 189